Prescription Drug Cost Sharing

25
Prescription Drug Cost Sharing

Transcript of Prescription Drug Cost Sharing

Prescription Drug Cost Sharing

SOURCE: Kaiser Family Foundation analysis of Marketplace plans in the 37 states with Federally Facilitated or Partnership exchanges in 2015 (including New Mexico, Oregon, and Nevada). Data are from Healthcare.gov Health plan information for individuals and families available here: https://www.healthcare.gov/health-plan-information/

Share of Plans by Type of Cost Sharing for Generic Prescriptions Plans with Combined Medical and Prescription Drug Deductible

5% 1%

21%

46% 48%

38% 28% 25%

34%

12% 18%

22% 28%

0%

10%

20%

30%

40%

50%

60%

70%

80%

90%

100%

Bronze Silver Gold Platinum

Copayment & Coinsurance

Coinsurance

Copayment

No Charge after Deductible

SOURCE: Kaiser Family Foundation analysis of Marketplace plans in the 37 states with Federally Facilitated or Partnership exchanges in 2015 (including New Mexico, Oregon, and Nevada). Data are from Healthcare.gov Health plan information for individuals and families available here: https://www.healthcare.gov/health-plan-information/

Share of Plans by Type of Cost Sharing for Generic Prescriptions Plans with Separate Medical and Prescription Drug Deductible

17% 20%

2%

98%

82% 78%

97%

2% 1% 1% 1%

0%

10%

20%

30%

40%

50%

60%

70%

80%

90%

100%

Bronze Silver Gold Platinum

Coinsurance

Copayment

No Charge

SOURCE: Kaiser Family Foundation analysis of Marketplace plans in the 37 states with Federally Facilitated or Partnership exchanges in 2015 (including New Mexico, Oregon, and Nevada). Data are from Healthcare.gov Health plan information for individuals and families available here: https://www.healthcare.gov/health-plan-information/

Average Copayment for Generic Drugs

$19

$13

$10

$8

$0

$2

$4

$6

$8

$10

$12

$14

$16

$18

$20

Bronze Silver Gold Platinum

SOURCE: Kaiser Family Foundation analysis of Marketplace plans in the 37 states with Federally Facilitated or Partnership exchanges in 2015 (including New Mexico, Oregon, and Nevada). Data are from Healthcare.gov Health plan information for individuals and families available here: https://www.healthcare.gov/health-plan-information/

Distribution of Copayment Amounts for Generic Drugs

5% 11%

15%

33%

11%

34%

55%

67%

22%

37%

24%

1%

26%

15%

6%

25%

3% 0%

11%

1%

0%

10%

20%

30%

40%

50%

60%

70%

80%

90%

100%

Bronze Silver Gold Platinum

Over $25

>$20 - $25

>$15 - $20

>$10 - $15

>$5 = $10

$5 or less

SOURCE: Kaiser Family Foundation analysis of Marketplace plans in the 37 states with Federally Facilitated or Partnership exchanges in 2015 (including New Mexico, Oregon, and Nevada). Data are from Healthcare.gov Health plan information for individuals and families available here: https://www.healthcare.gov/health-plan-information/

Average Coinsurance Rates for Generic Drugs

30% 29%

23%

26%

0%

5%

10%

15%

20%

25%

30%

35%

Bronze Silver Gold Platinum

SOURCE: Kaiser Family Foundation analysis of Marketplace plans in the 37 states with Federally Facilitated or Partnership exchanges in 2015 (including New Mexico, Oregon, and Nevada). Data are from Healthcare.gov Health plan information for individuals and families available here: https://www.healthcare.gov/health-plan-information/

Distribution of Coinsurance Rates for Generic Drugs

13% 17%

38%

20%

19%

34%

20%

10%

37%

20%

23%

50%

7% 4%

5% 0%

24% 25%

15% 20%

0%

10%

20%

30%

40%

50%

60%

70%

80%

90%

100%

Bronze Silver Gold Platinum

40% or more

>30% - >50%

>20% - 30%

>10% - 20%

10% or less

SOURCE: Kaiser Family Foundation analysis of Marketplace plans in the 37 states with Federally Facilitated or Partnership exchanges in 2015 (including New Mexico, Oregon, and Nevada). Data are from Healthcare.gov Health plan information for individuals and families available here: https://www.healthcare.gov/health-plan-information/

Share of Plans by Type of Cost Sharing for Preferred Prescriptions Plans with Combined Medical and Prescription Drug Deductible

36%

17%

8%

26% 58%

69% 91%

38%

26% 23%

9%

0%

10%

20%

30%

40%

50%

60%

70%

80%

90%

100%

Bronze Silver Gold Platinum

Coinsurance

Copayment

No Charge after Deductible

SOURCE: Kaiser Family Foundation analysis of Marketplace plans in the 37 states with Federally Facilitated or Partnership exchanges in 2015 (including New Mexico, Oregon, and Nevada). Data are from Healthcare.gov Health plan information for individuals and families available here: https://www.healthcare.gov/health-plan-information/

Share of Plans by Type of Cost Sharing for Preferred Prescriptions Plans with Separate Medical and Prescription Drug Deductible

81%

94% 93% 99%

19%

6% 7% 1%

0%

10%

20%

30%

40%

50%

60%

70%

80%

90%

100%

Bronze Silver Gold Platinum

Coinsurance

Copayment

SOURCE: Kaiser Family Foundation analysis of Marketplace plans in the 37 states with Federally Facilitated or Partnership exchanges in 2015 (including New Mexico, Oregon, and Nevada). Data are from Healthcare.gov Health plan information for individuals and families available here: https://www.healthcare.gov/health-plan-information/

Average Copayment for Preferred Drugs

$63

$47

$37

$28

$-

$10

$20

$30

$40

$50

$60

$70

Bronze Silver Gold Platinum

SOURCE: Kaiser Family Foundation analysis of Marketplace plans in the 37 states with Federally Facilitated or Partnership exchanges in 2015 (including New Mexico, Oregon, and Nevada). Data are from Healthcare.gov Health plan information for individuals and families available here: https://www.healthcare.gov/health-plan-information/

Distribution of Copayment Amounts for Preferred Drugs

7%

25%

2% 5%

27%

57%

6%

24%

48%

13%

47%

58%

13%

4%

6%

9% 4%

39%

3% 2%

0%

10%

20%

30%

40%

50%

60%

70%

80%

90%

100%

Bronze Silver Gold Platinum

Over $60

>$50 - $60

>$40 - $50

>$30 - $40

>$20 - $30

20% or less

SOURCE: Kaiser Family Foundation analysis of Marketplace plans in the 37 states with Federally Facilitated or Partnership exchanges in 2015 (including New Mexico, Oregon, and Nevada). Data are from Healthcare.gov Health plan information for individuals and families available here: https://www.healthcare.gov/health-plan-information/

Average Coinsurance Rates for Preferred Drugs

32%

30%

27% 27%

24%

25%

26%

27%

28%

29%

30%

31%

32%

33%

Bronze Silver Gold Platinum

SOURCE: Kaiser Family Foundation analysis of Marketplace plans in the 37 states with Federally Facilitated or Partnership exchanges in 2015 (including New Mexico, Oregon, and Nevada). Data are from Healthcare.gov Health plan information for individuals and families available here: https://www.healthcare.gov/health-plan-information/

Distribution of Coinsurance Rates for Preferred Drugs

2% 10%

17% 18%

24%

19% 12%

36% 39%

52%

64%

11%

11%

8% 27% 22%

11% 18%

0%

10%

20%

30%

40%

50%

60%

70%

80%

90%

100%

Bronze Silver Gold Platinum

40% or more

>30% - >40%

>20% - 30%

>10% - 20%

10% or less

SOURCE: Kaiser Family Foundation analysis of Marketplace plans in the 37 states with Federally Facilitated or Partnership exchanges in 2015 (including New Mexico, Oregon, and Nevada). Data are from Healthcare.gov Health plan information for individuals and families available here: https://www.healthcare.gov/health-plan-information/

Share of Plans by Type of Cost Sharing for Non-Preferred Prescriptions Plans with Combined Medical and Prescription Drug Deductible

36%

20%

8%

20%

40%

52%

88%

44% 40% 40%

11%

0%

10%

20%

30%

40%

50%

60%

70%

80%

90%

100%

Bronze Silver Gold Platinum

Coinsurance

Copayment

No Charge after Deductible

SOURCE: Kaiser Family Foundation analysis of Marketplace plans in the 37 states with Federally Facilitated or Partnership exchanges in 2015 (including New Mexico, Oregon, and Nevada). Data are from Healthcare.gov Health plan information for individuals and families available here: https://www.healthcare.gov/health-plan-information/

Share of Plans by Type of Cost Sharing for Non-Preferred Prescriptions Plans with Separate Medical and Prescription Drug Deductible

56%

75% 78%

69%

44%

25% 22%

31%

0%

10%

20%

30%

40%

50%

60%

70%

80%

90%

100%

Bronze Silver Gold Platinum

Coinsurance

Copayment

SOURCE: Kaiser Family Foundation analysis of Marketplace plans in the 37 states with Federally Facilitated or Partnership exchanges in 2015 (including New Mexico, Oregon, and Nevada). Data are from Healthcare.gov Health plan information for individuals and families available here: https://www.healthcare.gov/health-plan-information/

Average Copayment for Non-Preferred Drugs

$106

$85

$74

$55

$0

$20

$40

$60

$80

$100

$120

Bronze Silver Gold Platinum

SOURCE: Kaiser Family Foundation analysis of Marketplace plans in the 37 states with Federally Facilitated or Partnership exchanges in 2015 (including New Mexico, Oregon, and Nevada). Data are from Healthcare.gov Health plan information for individuals and families available here: https://www.healthcare.gov/health-plan-information/

Distribution of Copayment Amounts for Non-Preferred Drugs

1% 4% 8%

60%

34%

47%

66%

35%

30%

39%

22%

4%

27%

9% 2% 8%

1% 2%

0%

10%

20%

30%

40%

50%

60%

70%

80%

90%

100%

Bronze Silver Gold Platinum

Over $150

>$100 - $150

>$75 - $100

>$50 - $75

$50 or less

SOURCE: Kaiser Family Foundation analysis of Marketplace plans in the 37 states with Federally Facilitated or Partnership exchanges in 2015 (including New Mexico, Oregon, and Nevada). Data are from Healthcare.gov Health plan information for individuals and families available here: https://www.healthcare.gov/health-plan-information/

Average Coinsurance Rates for Non-Preferred Drugs

37% 37%

34%

33%

31%

32%

33%

34%

35%

36%

37%

38%

Bronze Silver Gold Platinum

SOURCE: Kaiser Family Foundation analysis of Marketplace plans in the 37 states with Federally Facilitated or Partnership exchanges in 2015 (including New Mexico, Oregon, and Nevada). Data are from Healthcare.gov Health plan information for individuals and families available here: https://www.healthcare.gov/health-plan-information/

Distribution of Coinsurance Rates for Non-Preferred Drugs

2% 6%

13%

3%

17%

22%

19%

10%

29% 15% 10%

16%

51% 56% 58%

71%

0%

10%

20%

30%

40%

50%

60%

70%

80%

90%

100%

Bronze Silver Gold Platinum

>30% - <50%

>20% - 30%

>10% - 20%

10% or less

SOURCE: Kaiser Family Foundation analysis of Marketplace plans in the 37 states with Federally Facilitated or Partnership exchanges in 2015 (including New Mexico, Oregon, and Nevada). Data are from Healthcare.gov Health plan information for individuals and families available here: https://www.healthcare.gov/health-plan-information/

Share of Plans by Type of Cost Sharing for Specialty Prescriptions Plans with Combined Medical and Prescription Drug Deductible

36%

22%

10%

1%

3%

9%

8%

1%

61% 68%

82%

98%

1% 1%

0%

10%

20%

30%

40%

50%

60%

70%

80%

90%

100%

Bronze Silver Gold Platinum

Copayment and Coinsurance

Coinsurance

Copayment

No Charge after Deductible

SOURCE: Kaiser Family Foundation analysis of Marketplace plans in the 37 states with Federally Facilitated or Partnership exchanges in 2015 (including New Mexico, Oregon, and Nevada). Data are from Healthcare.gov Health plan information for individuals and families available here: https://www.healthcare.gov/health-plan-information/

Share of Plans by Type of Cost Sharing for Specialty Prescriptions Plans with Separate Medical and Prescription Drug Deductible

12%

33% 34% 33%

88%

67% 65% 67%

0%

10%

20%

30%

40%

50%

60%

70%

80%

90%

100%

Bronze Silver Gold Platinum

Coinsurance

Copayment

SOURCE: Kaiser Family Foundation analysis of Marketplace plans in the 37 states with Federally Facilitated or Partnership exchanges in 2015 (including New Mexico, Oregon, and Nevada). Data are from Healthcare.gov Health plan information for individuals and families available here: https://www.healthcare.gov/health-plan-information/

Average Copayment for Specialty Drugs

$174 $179

$160

$139

$0

$20

$40

$60

$80

$100

$120

$140

$160

$180

$200

Bronze Silver Gold Platinum

SOURCE: Kaiser Family Foundation analysis of Marketplace plans in the 37 states with Federally Facilitated or Partnership exchanges in 2015 (including New Mexico, Oregon, and Nevada). Data are from Healthcare.gov Health plan information for individuals and families available here: https://www.healthcare.gov/health-plan-information/

Distribution of Copayment Amounts for Specialty Drugs

16% 8%

15%

39%

25% 47%

58%

23%

39%

23%

13%

28%

12% 14%

5% 2%

8% 8% 8% 8%

0%

10%

20%

30%

40%

50%

60%

70%

80%

90%

100%

Bronze Silver Gold Platinum

Over $250

>$200 - $250

>$150 - $200

>$100 - $150

$100 or less

SOURCE: Kaiser Family Foundation analysis of Marketplace plans in the 37 states with Federally Facilitated or Partnership exchanges in 2015 (including New Mexico, Oregon, and Nevada). Data are from Healthcare.gov Health plan information for individuals and families available here: https://www.healthcare.gov/health-plan-information/

Average Coinsurance Rates for Specialty Drugs

36% 36%

30%

28%

0%

5%

10%

15%

20%

25%

30%

35%

40%

Bronze Silver Gold Platinum

SOURCE: Kaiser Family Foundation analysis of Marketplace plans in the 37 states with Federally Facilitated or Partnership exchanges in 2015 (including New Mexico, Oregon, and Nevada). Data are from Healthcare.gov Health plan information for individuals and families available here: https://www.healthcare.gov/health-plan-information/

Distribution of Coinsurance Rates for Specialty Drugs

2% 4% 7% 8%

15% 17%

19% 11%

27% 23%

45% 52%

56% 56%

30% 29%

0%

10%

20%

30%

40%

50%

60%

70%

80%

90%

100%

Bronze Silver Gold Platinum

>30% - <50%

>20% - 30%

>10% - 20%

10% or less